{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:48:42Z","timestamp":1757702922681},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orthop\u00e4de"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00132-005-0901-y","type":"journal-article","created":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T13:49:21Z","timestamp":1134395361000},"page":"204-210","source":"Crossref","is-referenced-by-count":8,"title":["Nekrosen der Kieferknochen unter Bisphosphonattherapie","Necrosis of the jaws under bisphosphonate therapy"],"prefix":"10.1007","volume":"35","author":[{"given":"S.","family":"Hoefert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Eufinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"901_CR1","first-page":"1","volume":"30","author":"Agawala","year":"2004","unstructured":"Agawala S, Jain D, Joshi VR, Sule A (2004) Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology 30: 1\u20138","journal-title":"Rheumatology"},{"key":"901_CR2","unstructured":"Arzneimittelkommission der deutschen Apotheker (2004) In: Dtsch Apotheker Z 33: 3662"},{"key":"901_CR3","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (2004) In: Dtsch \u00c4rztebl 31\/32: 1843"},{"key":"901_CR4","unstructured":"Arzneimittelkommission der deutschen \u00c4rzteschaft (2005) In: Dtsch \u00c4rztebl 8: A529"},{"key":"901_CR5","unstructured":"Bartl R, Bartl C (2004) Osteoporose-Manual: Diagnostik, Pr\u00e4vention und Therapie. Springer, Berlin Heidelberg New York Tokio, S\u00a0125\u2013136"},{"key":"901_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/sonc.2002.34071","volume":"29","author":"Berenson","year":"2002","unstructured":"Berenson J (2002) Advances in the biology and treatment of myeloma bone disease. Semin Oncol 29: 11\u201316","journal-title":"Semin Oncol"},{"key":"901_CR7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1079-2104(97)90334-6","volume":"84","author":"Bouquot","year":"1997","unstructured":"Bouquot J, McMahon RE (1997) Alveolar osteonecrosis. Oral Surg Oral Med Oral Pathology 84: 229\u2013230","journal-title":"Oral Surg Oral Med Oral Pathology"},{"key":"901_CR8","first-page":"413","volume":"182","author":"Carter","year":"2005","unstructured":"Carter G, Goss AN, Doecke C (2005) Bisphosphonates and avascular necrosis of the jaw: a possible association. MJA 182: 413\u2013415","journal-title":"MJA"},{"key":"901_CR9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.orthres.2003.05.001","volume":"22","author":"Day","year":"2004","unstructured":"Day JS, Ding M, Bednarz P et al. (2004) Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. J Orthop Res 22: 465\u2013471","journal-title":"J Orthop Res"},{"key":"901_CR10","unstructured":"Ehrenfeld M, Winter W (2000) Entz\u00fcndungen des Knochens. In: Schwenzer N, Ehrenfeld M (Hrsg) Allgemeine Chirurgie: Zahn-, Mund- und Kieferheilkunde. Thieme, Stuttgart New York, S\u00a0193\u2013214"},{"key":"901_CR11","doi-asserted-by":"crossref","unstructured":"Green JR (2004) Bisphosphonates: preclinical review. Oncologist 9 [Suppl]: 3S\u201313S","DOI":"10.1634\/theoncologist.9-90004-3"},{"key":"901_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tripleo.2004.08.001","volume":"98","author":"Greenberg","year":"2004","unstructured":"Greenberg MS (2004) Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98: 259\u2013260","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"901_CR13","unstructured":"Harrison TR (2005) Onkologie und H\u00e4matologie. In: Dietl M, Suttorp N, Zeitz M (Hrsg) Harrisons Innere Medizin, 16.\u00a0Aufl. ABW Wissenschaftsverlag, Berlin, S\u00a0457\u2013554, 703\u2013710"},{"key":"901_CR14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.joms.2004.09.004","volume":"62","author":"Hellstein","year":"2004","unstructured":"Hellstein JW, Marek CL (2004) Bis-phossy jaw, phossy jaw, and the 21st century: Bisphophonate-associated complications of the jaws. J Oral Maxillofac Surg 62: 1563\u20131566","journal-title":"J Oral Maxillofac Surg"},{"key":"901_CR15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2005.01.010","volume":"63","author":"Hellstein","year":"2005","unstructured":"Hellstein JW, Marek CL, Pharm BS (2005) Bisphosphonate osteochemonecrosis (bis-phossy jaw): Is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63: 682\u2013689","journal-title":"J Oral Maxillofac Surg"},{"key":"901_CR16","unstructured":"Hoefert S, Eufinger H (2004) M\u00f6gliche unerw\u00fcnschte Wirkungen von Bisphosphonaten im Kieferbereich. ZM 94 Nr. 19: 50\u201353"},{"key":"901_CR17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1902\/jop.2003.74.9.1348","volume":"74","author":"Kaynak","year":"2003","unstructured":"Kaynak D, Meffert R, Bostanci H, G\u00fcnhan \u00d6, \u00d6zkaya \u00d6G (2003) A histopathological investigation on the effect of systemic administration of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the rat mandible. J Periodontol 74: 1348\u20131354","journal-title":"J Periodontol"},{"key":"901_CR18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2106\/JBJS.D.02192","volume":"87","author":"Kim","year":"2005","unstructured":"Kim HK, Randall TS, Bian H, Jenkins J, Garces A, Bauss F (2005) Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am 87: 550\u2013557","journal-title":"J Bone Joint Surg Am"},{"key":"901_CR19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcms.2003.07.009","volume":"32","author":"Kos","year":"2004","unstructured":"Kos M, Luczak K, Godzinski J, Klempous J (2004) Treatment of monostotic fibrous dysplasia with pamidronate. J Craniomaxillofac Surg 32: 10\u201315","journal-title":"J Craniomaxillofac Surg"},{"key":"901_CR20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (aredia) and zoledronate (zometa) induced avascular necrosis of the jaw: a growing epidemic. J Oral Maxillofac Surg 61: 1115\u20131118","journal-title":"J Oral Maxillofac Surg"},{"key":"901_CR21","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","volume":"21","author":"Migliorati","year":"2003","unstructured":"Migliorati CA (2003) Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 21: 4253\u20134254","journal-title":"J Clin Oncol"},{"key":"901_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","volume":"104","author":"Migliorati","year":"2005","unstructured":"Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone. Cancer 104: 83\u201393","journal-title":"Cancer"},{"key":"901_CR23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","volume":"104","author":"Plotkin","year":"1999","unstructured":"Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphophonates and calcitonin. J Clin Invest 104: 1363\u20131374","journal-title":"J Clin Invest"},{"key":"901_CR24","first-page":"417","volume":"182","author":"Purcell","year":"2005","unstructured":"Purcell PM, Boyd IW (2005) Bisphosphonates and osteonecrosis of the jaw. MJA 182: 417\u2013418","journal-title":"MJA"},{"key":"901_CR25","doi-asserted-by":"crossref","unstructured":"Robinson NA, Yeo JF (2004) Bisphophonates \u2014 a word of caution. Ann Acad Med Singapore 33 [Suppl]: 48S\u201349S","DOI":"10.47102\/annals-acadmedsg.V33N4p48S"},{"key":"901_CR26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","volume":"62","author":"Ruggiero","year":"2004","unstructured":"Ruggiero SL, Mehorotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62: 527\u2013534","journal-title":"J Oral Maxillofac Surg"},{"key":"901_CR27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.joms.2004.03.005","volume":"62","author":"Schwartz","year":"2004","unstructured":"Schwartz HC (2004) Osteonecrosis and bisphosphonates: correlation versus causation. J Oral Maxillofac Surg 62: 763\u2013764","journal-title":"J Oral Maxillofac Surg"},{"key":"901_CR28","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.joms.2003.09.001","volume":"61","author":"Tarassoff","year":"2003","unstructured":"Tarassoff P, Csermak K (2003) Avascular necrosis of the jaw: risk factors in metastatic cancer patients. J Oral Maxillofac Surg 61: 1238\u20131239","journal-title":"J Oral Maxillofac Surg"},{"key":"901_CR29","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","volume":"61","author":"Wang","year":"2003","unstructured":"Wang J, Goodger NM, Pogrel MA (2003) Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61: 1104\u20131107","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Der Orthop\u00e4de"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-005-0901-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00132-005-0901-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-005-0901-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T17:45:11Z","timestamp":1706809511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00132-005-0901-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1007\/s00132-005-0901-y","relation":{},"ISSN":["0085-4530","1433-0431"],"issn-type":[{"value":"0085-4530","type":"print"},{"value":"1433-0431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}